A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...
GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...
OPKO Health and Entera Bio, a developer of oral peptides and protein replacement therapies, entered into a license agreement ...
Gastroparesis is a chronic gastrointestinal condition that happens when the stomach can’t empty well, causing delayed ...
While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.
Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...
“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...
The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.
G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results